(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3...n bonds in the body's blood vessels significantly ..., according to a study conducted by National Insti...ding suggests the medication could be a new treatm...ertain complications of diabetes. The drug, ALT-71...
...ways been hampered by high rates of relapse, even ...om the Drug Abuse Program of the VU Medical Center...s of the National Institute on Drug Abuse (NIDA) h...ad to a new generation of medications to prevent r...
...gnosed and treated in many cases, say US doctors. ...n the legs and arms become blocked with the same k...ary artery disease. The best way of treating it is...kes walking painful, regular exercise does actuall...
...ring adulthood may protect against premenopausal b...n investigators have found that childhood milk con... cancer before the menopause.Dr Annette Hjartaker ...studied 48,844 premenopausal Norwegian women. Part...
Other Medicine News:(Date:10/6/2008)...The American College of Nutrition ...RNewswire/ -- New research on the benefits of,prob...e American College of,Nutrition (ACN) Annual Meeti...iotics in Health and Disease." Scientific experts ...discussed the potential uses for,probiotics in chi...
(Date:10/6/2008)...swire-FirstCall/ -- Genaera,Corporation (Nasdaq: ...,clinical trial of trodusquemine (MSI-1436), Genae... 2 diabetes and obesity. MSI-1436 is a novel,inhib...ontrols the function,of both the leptin and insuli...ite. In the study, MSI-1436 was found to be well-t...
(Date:10/6/2008)... for 9:00 AM ET Today -, SEATTLE, Oct. 6 /PRNewsw...DN) announced today that it has completed the plan...ouble-blind, placebo-controlled IMPACT,(IMmunother...own as D9902B),clinical trial designed to assess t...ve cellular immunotherapy PROVENGE(R) (sipuleucel-...
(Date:10/6/2008)...l/ -- Dendreon Corporation (Nasdaq:,DNDN) will hos... at 9:00 AM,ET (6:00 AM PT) to review the outcome ...py for Prostate AdenoCarcinoma Treatment, also kno...eucel-T), the Company,s investigational,active cel...prostate,cancer., Those interested may access ...
Breaking Medicine Technology:'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Standard Management Announces OTCBB Listing 725 1Standard Management Announces OTCBB Listing 725 2Minimally Invasive Heart Surgery Research Wins N I H Award 721 1Minimally Invasive Heart Surgery Research Wins N I H Award 721 2Boston University Biomedical Engineers Find Chink in Bacterias Armor 213 1Boston University Biomedical Engineers Find Chink in Bacterias Armor 213 2Boston University Biomedical Engineers Find Chink in Bacterias Armor 213 3Researcher developing new method for hearing loss assessment 717 1Researcher developing new method for hearing loss assessment 717 2...NESS WIRE)--July 9, 2007 - NexMed, Inc.,(NASDAQ: N...ents,based on the NexACT(R) drug delivery technolo...mpleted patient enrollment for Phase,III clinical ...omycosis (nail fungus). Pursuant to the terms of t...be entitled to a milestone,payment early next year...
..., July 08, 2007 /PRNewswire/ -- , - ENDORSE Global... Hospital-Wide Strategies to Optimize VTE Manageme... Provide Appropriate,prophylaxis to Prevent VTE , ...spital,patients and most of these at-risk patients...ding to data from the international,ENDORSE (Epide...
Other Medicine Technology:NexMed Announces Completion of Patient Enrollment in Two Pivotal,Phase 3 Studies for Anti-Fungal Product 2International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 2International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 3International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 4...quality at low light intensity. Leica DFC300 F low...y designed for imaging applications where limited ...reate bright, vibrant images without noise or colo...he Leica cameras allow dark and light objects to b...
Coolpix 4500 microscope package includes Coolpix 4500 digital camera, MDC-A relay lens and EH52 AC adapter.
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi
Hema-G Stains for Geometric Data Hemastainer. Formulated to provide consistent performance. Stains are quality control tested on human blood smears to ensure proper staining and absence of precipitat
Medicine Products: